Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000450911

Medchemexpress LLC Pitavastatin-d4 | 2070009-71-9 | 98.8% | 5 MG
SDP

Catalog No. 5000450911
Encompass_Preferred

Pitavastatin-d4 is a deuterium-labeled form of Pitavastatin, a potent HMG-CoA reductase inhibitor. It is effective in inhibiting cholesterol synthesis and acts as an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer.

  • Deuterium-labeled compound
  • Potent HMG-CoA reductase inhibitor
  • Inhibits cholesterol synthesis from acetic acid
  • Efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer
  • Possesses anti-atherosclerotic effects
  • Possesses anti-asthmatic and anti-osteoarthritis effects
  • Exhibits antineoplastic, neuroprotective, hepatoprotective, and reno-protective effects

Catalog No. 50-004-50911 Supplier Medchemexpress LLC Supplier No. HYB0144AS5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pitavastatin-d4 is a deuterium-labeled form of Pitavastatin, a potent HMG-CoA reductase inhibitor. It is effective in inhibiting cholesterol synthesis and acts as an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer.

  • Deuterium-labeled compound
  • Potent HMG-CoA reductase inhibitor
  • Inhibits cholesterol synthesis from acetic acid
  • Efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer
  • Possesses anti-atherosclerotic effects
  • Possesses anti-asthmatic and anti-osteoarthritis effects
  • Exhibits antineoplastic, neuroprotective, hepatoprotective, and reno-protective effects

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.